Agilent Funds University College Dublin Newman Fellowship in Quantitative Proteomics
News May 14, 2010
Agilent Technologies Inc. and University College Dublin (UCD) has announced the appointment of Dr. Ben Collins as the Agilent Technologies Newman Fellow in Quantitative Proteomics at the UCD Conway Institute of Biomolecular and Biomedical Research.
Dr. Collins’ research, under the supervision of Professor Steve Pennington, will focus on the development and application of advanced liquid chromatography mass spectrometry (LC/MS) methodologies to support a variety of biomedical research projects. Using Agilent LC/MS instruments, Dr. Collins will research methods for determining differences in the concentrations of large numbers of proteins in diverse samples.
Research projects range from identifying strategies to improve the safety evaluation of new drugs, to uncovering novel methods for early diagnosis of prostate cancer by screening blood proteins.
Agilent and the Proteome Research Center at the UCD Conway Institute have an existing collaboration focused on the development and application of advanced workflows for analysis of protein content in biological samples.
“As a leading technology partner to academia, the funding of the Newman Fellowship reflects our core belief that investing in the next generation of thought leaders is a crucial part of moving science forward,” said Padraig McDonnell, country general manager, Agilent Ireland. “We look forward to working closely with Professor Pennington and his team at UCD to further research and understanding in the field of quantitative proteomics.”
Funding for the Newman Fellowship was made possible through Agilent’s university research program, which fosters the advancement and application of measurement technologies at universities around the world.
For more than 21 years, leading Irish and multinational business, industry and philanthropy have funded high-caliber, postdoctoral research across the humanities and sciences through the UCD Newman Fellowship Program. Each Newman Fellow is funded for a two-year period to conduct a major research project leading to publication. The fellowships build on the complementary strengths and needs of the University and the corporate sector.
“The Newman Fellowship Program is an important element of UCD’s research strategy, providing opportunities at postdoctoral level for high-caliber national and international researchers, generously funded by philanthropy, business and industry,” said Jessica Kavanagh, UCD director of Trusts & Foundations. “The University provides facilities for these talented and energetic Fellows and supports them academically during their tenure. Working alongside their academic mentors, the Fellows contribute greatly to the academic research agenda of their particular discipline and to university life in general.”
This year celebrates the 21st anniversary of the UCD Newman Fellowship Program and recognizes the 120 Newman Fellows who have undertaken research in diverse areas of study across the University.
Ataxin Links Long Term-Memory and NeurodegenerationNews
Scientists have just discovered that a small region of a cellular protein that helps long-term memories form also drives the neurodegeneration seen in motor neuron disease (MND)READ MORE
BioAscent Establishes Integrated Drug Discovery Services OfferingNews
Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.READ MORE
Lab Innovations returns to the NEC, Bimingham , UKNews
Save the date for the UK’s only lab-dedicated exhibition showcase!READ MORE
Comments | 0 ADD COMMENT
International Conference on Biobetters and Regulatory Affairs
Jun 27 - Jun 28, 2018